Neonatal Outcomes of Live Births after Blastocyst Biopsy in Preimplantation Genetic Testing Cycles: A Follow-up of 1721 Children

Hui He,Shuang Jing,Chang Fu Lu,Yue Qiu Tan,Ke Li Luo,Shuo Ping Zhang,Fei Gong,Guang Xiu Lu,Ge Lin
DOI: https://doi.org/10.1097/ogx.0000000000000748
2019-01-01
Abstract:(Abstracted from Fertil Steril 2019;112:82–88) Blastocyst biopsy as a means of preimplantation genetic testing (PGT) continues to increase in popularity and might provide a greater number of viable cells per biopsy compared with cleavage-stage biopsy. The increased number of testable cells enables the application of comprehensive chromosome screening modalities including next-generation sequencing, as well as the combination of multiple genetic tests.
What problem does this paper attempt to address?